XAIR Stock Analysis: Buy, Sell, or Hold?
XAIR - Beyond Air, Inc. Common Stock
$5.54
-1.95 (-26.06%)
▼
5d:
+1161.48%
30d:
+1372.85%
90d:
+778.89%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When XAIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: XAIR is 118.0% above its trading range ($2.54). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: XAIR is 118.0% above its trading range ($2.54). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: XAIR is currently trading at $5.54, which is considered extended relative to its 30-day fair value range of $-0.76 to $2.54.
Technical Outlook: Technically, XAIR is in a strong downtrend. The price is approaching resistance at $0.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 26.1% recently.
Market Sentiment: XAIR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $160.00 (+2036.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XAIR is in a strong downtrend. The price is approaching resistance at $0.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 26.1% recently.
Market Sentiment: XAIR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $160.00 (+2036.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.76 -
$2.54
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+118.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-26.1%)
- BULLISH: Trading 2036.2% below Wall St target ($160.00)
- WARNING: Recommendation downgraded due to 118.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.76 -
$2.54
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.39
Resistance Level
$0.51
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.21
Wall Street Target
$160.00
(+2036.2%)
Revenue Growth (YoY)
65.5%
Share & Embed Analysis
Last updated: July 14, 2026 1:00 PM ET
Data refreshes hourly during market hours. Next update: 2:00 PM
Data refreshes hourly during market hours. Next update: 2:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XAIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
